oasis trial semaglutide The first GLP-1 weight-loss pill: what the 4 found ECO 2026 - OASIS 4:

Shift Toward Lighter Pigment Shift Toward Lighter Pigment Some studies suggest glutathione may promote the formation of pheomelanin , a lighter pigment, rather than eumelanin , which produces darker tones

BPAs potential health risks: pregnancy, fertility, obesity, and diabetes, and the socioeconomic confounders in the data [1:08:30]

Novo Nordisk 's January 2026 launch of the FDA-approved Wegovy pill has introduced a new administration option alongside the established Wegovy shot, prompting questions from patients evaluating which formulation may align with their treatment goals

Compounded versions try to follow similar dosing practices